EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Heparin Vs Enoxaparin: Effects On D-Dimer And Hospital Stay In Covid-19 Patients

Fonny Cokro, Novita Suryamin, Dion Notario, Agnes Anania Triavika Sahamastuti, Catherine Keiko Gunawan, Anton Sumarpo

Jurnal Ilmu Kedokteran dan Kesehatan · 04.04.2026 · 13 (3) · 651-659

DOI: 10.33024/jikk.v13i3.23094 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Jurnal Ilmu Kedokteran dan Kesehatan, online erschienen am 04.04.2026. Verfasst von Fonny Cokro und 5 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Elevated d-dimer levels due to venous thromboembolism and hypercoagulability in covid-19 patients play a role in disease severity and poor clinical outcomes. This study aims to compare the effectiveness of heparin and enoxaparin, two recommended anticoagulants, in reducing d-dimer levels and hospital stay duration in hospitalized covid-19 patients. This retrospective cohort study involved 106 hospitalized covid-19 patients with abnormal d-dimer levels treated between March 2020 and March 2023. The assessment included changes in d-dimer levels and hospitalization duration. Statistical analyses were performed using stata software. Patients receiving enoxaparin were 5.913 times more likely to experience a reduction in d-dimer levels compared to those receiving heparin (p=0.021). While smoking status (or=0.034; p=0.001) and the number of comorbidities (or=11.247; p=0.018) were notable factors influencing d-dimer reduction, enoxaparin administration was linked to significantly longer hospitalization (p=0.024). The severity of covid-19 also had a substantial impact on hospital stays, with severe (β = 5.757; p= 0.004) and critical (β = 9.147; p 0.001) cases requiring extended care. Thus, enoxaparin demonstrates greater efficacy in reducing d-dimer levels in hospitalized covid-19 patients, though at the cost of prolonged hospital stays.

Zitieren

APA

Cokro, F., Suryamin, N., Notario, D., Sahamastuti, A. A. T., Gunawan, C. K., & Sumarpo, A. (2026). Heparin Vs Enoxaparin: Effects On D-Dimer And Hospital Stay In Covid-19 Patients. Jurnal Ilmu Kedokteran dan Kesehatan, 13(3), 651-659. https://doi.org/10.33024/jikk.v13i3.23094

Vancouver

Cokro F, Suryamin N, Notario D, Sahamastuti AAT, Gunawan CK, Sumarpo A. Heparin Vs Enoxaparin: Effects On D-Dimer And Hospital Stay In Covid-19 Patients. Jurnal Ilmu Kedokteran dan Kesehatan. 2026;13(3):651-659. doi:10.33024/jikk.v13i3.23094

BibTeX
@article{Cokro2026,
  author = {Cokro, Fonny and Suryamin, Novita and Notario, Dion and Sahamastuti, Agnes Anania Triavika and Gunawan, Catherine Keiko and Sumarpo, Anton},
  title = {Heparin Vs Enoxaparin: Effects On D-Dimer And Hospital Stay In Covid-19 Patients},
  journal = {Jurnal Ilmu Kedokteran dan Kesehatan},
  year = {2026},
  volume = {13},
  number = {3},
  pages = {651--659},
  doi = {10.33024/jikk.v13i3.23094}
}
Kostenlos starten →